Citizens JMP's Devin Ryan talks Coinbase results
Devin Ryan, Citizens JMP senior analyst, joins 'Closing Bell Overtime' to talk Coinbase earnings. What would Nike be without ...
Coinbase Benefits From Strong Near-Term Momentum, 2025 Is Off to a Good Start: JMP
The broker raised its Coinbase price target to $475 from $400 while maintaining its market outperform rating on the stock.
JMP Securities Reaffirms Their Hold Rating on LXP Industrial Trust (LXP)
JMP Securities analyst Mitchell Germain maintained a Hold rating on LXP Industrial Trust (LXP – Research Report) today. The company’s shares ...
JMP Securities Sticks to Its Buy Rating for Life360, Inc. (LIF)
In a report released today, Andrew Boone from JMP Securities reiterated a Buy rating on Life360, Inc. (LIF – Research Report), with a price ...
JMP Securities maintains $220 target on Digital Realty stock
JMP Securities reiterated its Market Outperform rating on Digital Realty Trust (NYSE:DLR) with a steady price target of ...
Enanta Pharmaceuticals’ (ENTA) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...
Redwood Trust targets 30% volume growth for Sequoia in 2025 with $2B Aspire platform expansion
Management anticipates a 30% year-over-year increase in Sequoia volumes, targeting a return on capital of approximately 20% for 2025. Aspire's expanded mandate is expected to access a $100 billion ...
Esperion Therapeutics’ (ESPR) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities reissued their market outperform rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. They ...